RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ConvaTec Group Stock

ConvaTec Group ROCE 2024

ConvaTec Group ROCE

0.17

Ticker

CTEC.L

ISIN

GB00BD3VFW73

WKN

A2AUD3

In 2024, ConvaTec Group's return on capital employed (ROCE) was 0.17, a 11.99% increase from the 0.15 ROCE in the previous year.

ConvaTec Group Aktienanalyse

What does ConvaTec Group do?

ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling ConvaTec Group's Return on Capital Employed (ROCE)

ConvaTec Group's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing ConvaTec Group's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

ConvaTec Group's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in ConvaTec Group’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about ConvaTec Group stock

What is the ROCE (Return on Capital Employed) of ConvaTec Group this year?

The ROCE of ConvaTec Group is 0.17 undefined this year.

How has the ROCE (Return on Capital Employed) of ConvaTec Group developed compared to the previous year?

The ROCE of ConvaTec Group has increased by 11.99% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of ConvaTec Group?

A high Return on Capital Employed (ROCE) indicates that ConvaTec Group has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of ConvaTec Group?

A low ROCE (Return on Capital Employed) can indicate that ConvaTec Group has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from ConvaTec Group impact the company?

An increase in the ROCE of ConvaTec Group can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of ConvaTec Group affect the company?

A decrease in ROCE of ConvaTec Group can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of ConvaTec Group?

Some factors that can affect ConvaTec Group's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of ConvaTec Group so important for investors?

The ROCE of ConvaTec Group is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can ConvaTec Group take to improve the ROCE?

To improve the ROCE, ConvaTec Group can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does ConvaTec Group pay?

Over the past 12 months, ConvaTec Group paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 1.64 %. For the coming 12 months, ConvaTec Group is expected to pay a dividend of 0.05 USD.

What is the dividend yield of ConvaTec Group?

The current dividend yield of ConvaTec Group is 1.64 %.

When does ConvaTec Group pay dividends?

ConvaTec Group pays a quarterly dividend. This is distributed in the months of May, September, May, September.

How secure is the dividend of ConvaTec Group?

ConvaTec Group paid dividends every year for the past 0 years.

What is the dividend of ConvaTec Group?

For the upcoming 12 months, dividends amounting to 0.05 USD are expected. This corresponds to a dividend yield of 1.62 %.

In which sector is ConvaTec Group located?

ConvaTec Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von ConvaTec Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ConvaTec Group from 10/4/2024 amounting to 0.014 USD, you needed to have the stock in your portfolio before the ex-date on 8/22/2024.

When did ConvaTec Group pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of ConvaTec Group in the year 2023?

In the year 2023, ConvaTec Group distributed 0.046 USD as dividends.

In which currency does ConvaTec Group pay out the dividend?

The dividends of ConvaTec Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ConvaTec Group

Our stock analysis for ConvaTec Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ConvaTec Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.